Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 2, Pages e56505
Publisher
Public Library of Science (PLoS)
Online
2013-02-15
DOI
10.1371/journal.pone.0056505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
- (2012) Karl H. Plate et al. ACTA NEUROPATHOLOGICA
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
- (2011) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab does not increase the risk of remote relapse in malignant glioma
- (2010) Antje Wick et al. ANNALS OF NEUROLOGY
- Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
- (2010) Jennifer P. Morton et al. GASTROENTEROLOGY
- Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
- (2010) Laura J. Lewis-Tuffin et al. PLoS One
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
- (2009) K. V. Lu et al. CANCER RESEARCH
- Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury
- (2008) Qiang Li et al. BIOCHEMICAL JOURNAL
- Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
- (2008) Felix Bokstein et al. CANCER
- Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
- (2008) Susanne Kleber et al. CANCER CELL
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
- PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel
- (2008) L. Yang et al. CLINICAL CANCER RESEARCH
- Metabolism and Disposition of Dasatinib after Oral Administration to Humans
- (2008) L. J. Christopher et al. DRUG METABOLISM AND DISPOSITION
- p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression
- (2008) Edwin Soto et al. JOURNAL OF CELL BIOLOGY
- Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases
- (2008) Sheikh A. Ali et al. JOURNAL OF NEUROSURGERY
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now